Aimble
Aimble is an AI drug development company that offers drugs to treat intractable diseases.
Aimble operates in biopharma, biotechnology, pharmaceutical based in Asia-Pacific (APAC), founded in 2020.
Aimble is positioned in biopharma, biotechnology, pharmaceutical, a segment that rewards a clear, focused offering.
The business is associated with Asia-Pacific (APAC).
Its current recorded stage is Non_Equity_Assistance.
Recorded headcount: c_00001_00010 employees.
Total disclosed funding stands at about $400M.
| Sector | Biopharma, Biotechnology, Pharmaceutical |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | non_equity_assistance |
| Total funding | $400,000,000 |
Website: www.aimble.com
Sign in to view the contact information we hold for Aimble.
Create a free account
Create a free account